{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Science News Daily","title":"Sellas Reports Promising AML Phase 2, Promising Ropeginterferon Boosts Blood Cancer Therapy, Cosmic Knots Reveal Matter Origins, Regeneron Drug Promises in MY Health, and more...","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/45b158c6\"></iframe>","width":"100%","height":180,"duration":766,"description":"(0:10): SELLAS Life Sciences Reports Promising Phase 2 Results for AML Treatment at ASH 2025(2:33): AOP Health Showcases Promising Ropeginterferon Results for Blood Cancer Treatment at ASH Meeting(5:17): Japanese Physicists Propose Cosmic Knots Theory to Solve Matter Origin Mysteries(7:39): Regeneron's Lynozyfic Shows Promise as Frontline Therapy for Multiple Myeloma in LINKER Trials(10:11): Groundbreaking Study Maps Gut-Liver Pathway, Paving New Avenues for Diabetes and Obesity TreatmentTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news.\nImage credit: SSBCrack News","thumbnail_url":"https://img.transistorcdn.com/je4-HZPgrBlk_-irwBJ1aU1GY9y3XNHXezHh1JTxzqw/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQ3MTgzLzE3MDY3/MjM4ODUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}